At
June 30, 2026 and 2025, the Company excluded the outstanding securities summarized below, which entitle the holders thereof to acquire
shares of common stock, from its calculation of earnings per share, as their effect would have been anti-dilutive.
Schedule
of Anti-dilutive Securities Excluded from Computation of Earnings Per Share
| | |
2026 | | |
2025 | |
| | |
June 30, | |
| | |
2026 | | |
2025 | |
| Common stock warrants (excluding pre-funded warrants) | |
| 7,683,891 | | |
| 1,275,758 | |
| Common stock options | |
| 593,059 | | |
| 744,726 | |
| Total | |
| 8,276,950 | | |
| 2,020,484 | |
|